A light at the end of the tunnel is beginning to be seen thanks to Pfizer’s new vaccine, developed in collaboration with Biontech. After so much suffering, a glimmer of hope has touched the world, despite all the complications of the case that this vaccine brings with it. This drug, which has yet to be approved from the EMA in Europe and by the FDA for the USA, it must be stored in the cold and to be precise at about -75 ° C.
On the method of transport and other doubts, the competent people are already working to solve these problems. This in view of the nearly 400 million doses destined for Europe. But in a climate of fear, people want to know who will receive the Covid vaccine first. The doses dedicated to Italy, in fact, will be staggered over time.
The new drug
The drug was developed by Pfizer in collaboration with Biontech, whose shares have seen a big leap forward by increasing the assets of Sahin and Tureci (founders of Biontech) by 4 billion dollars. The world is thus facing the first vaccine created on mRna technology, but in the beginning it will not be for everyone.
Who will get the Covid vaccine first?
The commissioner for the Covid emergency, Domenico Arcuri, during the press conference on the coronavirus situation in Italy stated that: “The vaccine is coming (…), but it will not be available to everyone”. The commissioner is expecting a first wave of vaccines as early as January. He is also in charge of consulting the Regions for the construction of Covid Hotels. In this way, there is the hope of easing the situation in hospitals.
During the conference, Arcuri added that the categories to be vaccinated are still being decided well. However, he stated that “health workers will be among the first, along with older people who are more fragile”. The commissioner also added that the distribution will not be on a regional basis, but there will be a centralization of the mechanism by the Government.
Deepening
